The Global Health Progress initiative seeks to bring research-based biopharmaceutical companies and global health leaders together to improve access to medicine and health care in the developing world. In addition to serving as a convening point for the industry on global health topics, the initiative engages with global health organizations; lends advocacy support to shared goals; identifies best practices for programs that address health needs, and facilitates partnership and research and development efforts to fight neglected diseases in the developing world.
Through meaningful public-private partnerships with others in the field, including policymakers in the developed and developing world, multi-lateral institutions, non-governmental organizations, and academia we can help shape sustainable solutions that improve the health of all people.
Global Health Progress' expert working group provides insight, expertise and guidance into regional and global health challenges. The expert working group includes:
Dr. Jeff Sturchio, Senior Partner at Rabin Martin
Eva Maria Ruiz de Castilla, Director of Esperantra
Ratna Devi, CEO of DakshamA Health & Education
David Taylor, Professor of Pharmaceutical and Public Health Policy at The UCL School of Pharmacy